Privia Health Group Files 8-K/A Amendment
Ticker: PRVA · Form: 8-K/A · Filed: May 29, 2024 · CIK: 1759655
| Field | Detail |
|---|---|
| Company | Privia Health Group, Inc. (PRVA) |
| Form Type | 8-K/A |
| Filed Date | May 29, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing, corporate-governance
TL;DR
Privia Health Group filed an amendment to a shareholder vote filing. Check for updates.
AI Summary
Privia Health Group, Inc. filed an amendment (8-K/A) on May 29, 2024, to a previous filing concerning matters submitted to a vote of security holders. The original event date was May 22, 2024. The company is incorporated in Delaware and headquartered in Arlington, Virginia.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed regarding security holder votes.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, likely for administrative or minor corrections, and does not appear to introduce new material risks.
Key Players & Entities
- Privia Health Group, Inc. (company) — Registrant
- May 22, 2024 (date) — Earliest event date
- May 29, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Arlington, Virginia (location) — Principal executive offices
FAQ
What type of filing is this?
This is a Form 8-K/A, which is an amendment to a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the exact name of the company filing this amendment?
The exact name of the registrant is Privia Health Group, Inc.
When was the earliest event reported in this filing?
The earliest event reported was on May 22, 2024.
On what date was this amendment filed?
This amendment was filed on May 29, 2024.
Where are Privia Health Group, Inc.'s principal executive offices located?
Privia Health Group, Inc.'s principal executive offices are located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.
Filing Stats: 799 words · 3 min read · ~3 pages · Grade level 11.2 · Accepted 2024-05-29 16:06:02
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo
Filing Documents
- prva-20240522.htm (8-K/A) — 45KB
- 0001759655-24-000099.txt ( ) — 178KB
- prva-20240522.xsd (EX-101.SCH) — 2KB
- prva-20240522_lab.xml (EX-101.LAB) — 24KB
- prva-20240522_pre.xml (EX-101.PRE) — 14KB
- prva-20240522_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders On May 22, 2024, the Company held the Annual Meeting via live webcast. At the Annual Meeting, the Company's stockholders approved all five proposals. Proposal No. 1: Election of directors. The following four nominees were elected to serve as Class II directors for a term expiring at the Company's 2027 Annual Meeting of Stockholders, or until such director's respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Nominee Votes For Votes Withheld Broker Non-Votes Thomas McCarthy 99,268,746 3,905,963 11,085,362 Parth Mehrotra 102,934,560 1,005,791 10,319,720 Dr. Jaewon Ryu 99,347,055 3,827,654 11,085,362 William (Bill) Sullivan 65,283,936 37,861,267 11,114,868 Proposal No. 2: Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. The Company's stockholders approved, on a non-binding basis, the compensation of our named executive officers. Votes For Votes Against Abstentions Broker Non-Votes 96,616,303 2,663,618 4,660,430 10,319,720 Proposal No. 3: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment of PricewaterhouseCoopers LLP was ratified. Votes For Votes Against Abstentions Broker Non-Votes 110,149,647 95,394 4,015,030 — Proposal No. 4: Amend and restate the Company's amended and restated certificate of incorporation (the "Charter") to remove supermajority voting standards. The proposal to amend and restate the Charter to remove supermajority voting provisions was approved. Votes For Votes Against Abstentions Broker Non-Votes 99,807,247 96,832 4,036,272 10,319,720 Proposal No. 5: Amend and restate the Company's Charter to allow for exculpation of officers as permitted by Delaware law. The proposal to amend and restate the Charter to remove o
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: May 29, 2024 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer